Meet 2025 President’s Innovation Challenge Winner: Modulate Bio Modulate Bio is developing precision therapies for neurological disorders including Essential Tremor, epilepsy, and anxiety. By targeting specific brain receptors, their medicines restore healthy function without the risks of over-activation—providing safer, long-term treatment options. With their lead drug moving into human trials, Modulate Bio could deliver the first new Essential Tremor therapy in over half a century. Based at Pa